SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Strategies & Market Trends : Cents and Sensibility - Kimberly and Friends' Consortium -- Ignore unavailable to you. Want to Upgrade?


To: $Mogul who wrote (36258)12/1/1999 11:15:00 AM
From: Jim B  Respond to of 108040
 
that's what I'm counting on :)

jim



To: $Mogul who wrote (36258)12/1/1999 11:29:00 AM
From: ciVic  Read Replies (1) | Respond to of 108040
 
$Mogul...do you have a link to the IGLD/MSFT site? eom

ciV



To: $Mogul who wrote (36258)12/1/1999 11:49:00 AM
From: Kimberly Lee  Read Replies (1) | Respond to of 108040
 
buying DAGM, 3 5/8, 11/16 (1.3M in the float, OS=2.9M, 52week high = 7 and is profitable) on a small brokerage's recommendation today. The fundies look decent:
ISSUE DATA (11/26/99) PER SHARE DATA RATIOS
Price $ 2.81 EPS (TTM) $ 0.11 P/E (TTM) 26.29
52W High $ 7.00 Div. Rate $ 0.00 Yield 0.00 %
52W Low $ 2.70 Book Value $ 3.09 Price/Book 0.91
Shrs Out 2.93 Mil Cash $ 2.44 ROE (TTM) 13.29 %
Float 1.30 Mil Rev (TTM) $ 1.78 ROA (TTM) 9.08 %
Mon. Vol 0.31 Mil Curr. Ratio 4.12
Beta NA LT Dbt/Eqty 0.00
BRIEF: Dag Media Inc., publishes and distributes two
yellow page directories, the Jewish Israeli Yellow Pages
and the Master Guide, in print and on the world wide web.
These directories cover the New York metropolitan area.
For the 9 months ended 9/30/99, net revenues increased 66%
to $4.4M. Net income increased 48% to $876K. Revenues
benefitted from increased publications and higher rates.
Earnings were partially offset by increased S/G/A costs.



To: $Mogul who wrote (36258)12/1/1999 11:52:00 AM
From: Kimberly Lee  Read Replies (3) | Respond to of 108040
 
here is the news on DAGM today: (COMTEX) B: LEADING FINANCIAL FIRM RECOMMENDS DAG MEDIA AS SMART STOC
B: LEADING FINANCIAL FIRM RECOMMENDS DAG MEDIA AS SMART STOCK BUY; SAYS TO BUY
AT 3-5/16; PRICE TARGET OF $7-8 IN NEXT 18 MONTHS

NEW YORK, Dec 1, 1999 /PRNewswire via COMTEX/ -- Wallstreet Research,
a prominent Los Angles-based financial institution, recommends DAG
Media, Inc. (Nasdaq: DAGM), the leading independent print and online
publisher of yellow pages directories, as a stock to buy, with expected
significant price appreciation within the next twelve months.
Wallstreet Research believes that DAG Media has reached its price
support level and trades near its lows.

The firm's report recommends buying the stock at 3-5/16 for investors
seeking high reward potential with corresponding risk. Wallstreet
Research have targeted the price of $7-8 in the next eighteen months.

Trading on the Nasdaq since May, 1999, DAG Media has established itself
as one of the most innovative and fastest-growing niche-oriented
publishers of yellow pages directories. The company is set to publish
New Yellow, a print and online general-interest yellow pages directory
that is challenging the monopoly of the Bell Atlantic Yellow Pages in
the New York City market in March, 2000.

The Wallstreet Research report states that the added-goods and services
are competitive features that offer an attractive product compared to
Bell Atlantic. New Yellow will publish local directory content and
lists thousands of New York Businesses plus value added data in a
user-friendly, organized and attractive format. DAG Media plans to
distribute approximately one million copies of New Yellow.

"We are pleased with Wallstreet's analysis and recommendation,"
commented CEO and president Assaf Ran. "DAG's success and continuing
growth is due to variety of factors including smart, cost-cutting
management, an aggressive sales force, expanded e-commerce activities,
and our ability to implement effective market strategies that
consistently keep us at pace with our competitors."

SOURCE DAG Media, Inc.
(C) 1999 PR Newswire. All rights reserved.
prnewswire.com
-0-
CONTACT: Lori Rosen, or Frank DeLuca, 212-255-8455, for DAG Media

WEB PAGE: jewishyellow.com

GEOGRAPHY: New York
California

INDUSTRY CODE: PUB
FIN

SUBJECT CODE: RTG

*** end of story ***



To: $Mogul who wrote (36258)12/1/1999 12:40:00 PM
From: Kimberly Lee  Read Replies (2) | Respond to of 108040
 
buying MCNS 9. News of Media Metrix rate MCNS highest number of page views per visitor and the longest visits among all health sites, above Dr.KOOP, WebMD... (COMTEX) B: Consistent 'Stickiness' Figures Put Mediconsult At Number
B: Consistent 'Stickiness' Figures Put Mediconsult At Number One

NEW YORK, Dec 1, 1999 (BUSINESS WIRE) --



- Latest Traffic Data From Media Metrix Demonstrate
Mediconsult Is The Clear Leader In Retaining Unique Visitors -

Latest independent figures from Media Metrix confirm that Mediconsult
(NASDAQ:MCNS) (www.mediconsult.com) is the leading Internet healthcare
family of sites in terms of 'stickiness,' with the highest number of
page views per visitor and the longest visits. Additionally,
Mediconsult set a corporate record for the month, with 19 million page
views.

Media Metrix numbers include all sites in the Mediconsult network, with
the exception of Physicians' Online (www.pol.net). Internal page view
numbers, which include Physicians' Online, are regularly audited by
I/PRO and BPA Interactive.

Data from Media Metrix, an independent provider of Internet audience
measurement products and services, confirm that Mediconsult is
maintaining its leadership status by a very healthy margin. During
October 1999, visitors viewed an average of 11.8 pages, and the average
number of minutes spent on the site for the month was 13.7. Comparative
sites averaged between five and nine pages per visitor, per month and a
duration of three to six minutes. In addition to the growth in the
'stickiness' numbers, Mediconsult has enjoyed a 22 percent rise in
unique visitors per month from September to October.

"Mediconsult is differentiating itself by putting the emphasis on the
quality of our visitors, not quantity," said Ian Sutcliffe, president
of Mediconsult. "We provide deep, compelling information which attracts
healthcare consumers with very specific needs. This captive audience
also is valuable to pharmaceutical sponsors and physicians. In addition
to the Media Metrix data, our internal computer logs confirm that the
Mediconsult family of sites, including Physicians' Online, generated
more than 19 million page views for the month of October. This is a
record for the company and reinforces our leadership position in the
marketplace."

"These figures conclusively prove Mediconsult is delivering the right
message to the right audience," Sutcliffe continued. "Our high traffic
numbers, while significant on their own, are more meaningful because
our visitors return frequently and spend time on the site."

The financial analysts also understand the value of duration and
visitor loyalty.

"Mediconsult.com is the clear leader in driving site stickiness," wrote
Josh Fisher, research analyst with WR Hambrecht and Co., regarding the
September Media Metrix figures that showed average visit time increased
by 15 minutes from January to September 1999.

In his report, Fisher continued, "We believe Mediconsult's site
stickiness is related to the perceived value of its content, which
focuses on severe, chronic illnesses and therefore attracts motivated
patients and caregivers. This excellent stickiness, which is imperative
to advertisers, positions Mediconsult to win Internet advertising
business from healthcare companies, in particular pharmaceutical
companies. We expect pharmaceutical sponsors, having thus far only
dipped their toes, to dive head first into Internet marketing very
soon."



About Mediconsult.com, Inc.

Mediconsult.com, Inc. through its family of sites is a leading
provider of physician and patient healthcare information and services
on the World Wide Web. Founded in 1996 with its flagship Web site,
www.mediconsult.com, the company's mission is to improve patient
outcomes through information and tools that educate doctors, empower
patients and build on the doctor/patient relationship. By educating and
empowering consumers to manage their health with in-depth medical
information, active support and interactive tools, Mediconsult prepares
patients to work effectively with their healthcare provider. By
providing physicians with the most current healthcare information and a
private community of peers, physicians can offer their patients a
higher level of care. This unique, integrated approach has resulted in
the largest and most loyal following of medical Web site visitors and a
leadership position in the online health industry.



The Mediconsult family of sites and communities include:

Mediconsult.com (www.mediconsult.com), the medical Web destination
patients use most;

Mydoctor.com (www.mydoctor.com), visit your doctor online; Physicians'
Online (www.pol.net), the world's largest online physician community;

Heart Information (www.heartinfo.com), heart health for patients and
physicians;

PharmInfo (www.pharminfo.com), current and in-depth drug information;

Cyberdiet (www.cyberdiet.com), fitness and nutrition resource and
community;

INCIID (www.inciid.org), infertility information and support;
Mediconsultinc.com (www.mediconsultinc.com), redefining medicine
through the Internet.

Certain statements in this release, such as management's view of future
revenues and expenses, may be forward-looking statements that are
subject to risks and uncertainties that could cause actual results to
differ materially from those projected. Potential risks and
uncertainties include such factors as acceptance of the Company's
products and services, competition and other risks described in the
Company's filings with the Securities and Exchange Commission.



Copyright (C) 1999 Business Wire. All rights reserved.



Distributed via COMTEX.
-0-
CONTACT: Mediconsult.com, Inc.
Ellen L. Turbeville, 914/332-6100 (ext. 283)
eturbeville@mediconsult.com
or
Corporate Ink
Lisa-Marie Cashman, 617/969-9192
lcashman@corporateink.com